Endo Shareholders Fight Bid To Toss Opioid Safety Suit

By Cara Bayles (May 7, 2018, 8:57 PM EDT) -- A proposed class of Endo International PLC shareholders on Friday blasted Endo's argument that their suit should be tossed because the drugmaker couldn't have foreseen the fallout of the opioid crisis, telling a Pennsylvania federal judge the company knowingly misrepresented the safety of its Opana drug before pulling it from the market....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!